Doxorubicin (DOX)-induced toxicity and resistance are major obstacles in chemotherapeutic
approaches. Despite effective in the treatment of numerous malignancies, some clinicians …

Doxorubicin (DOX) is an anthracycline antibiotic, which is effectively used in the treatment of
different malignancies, such as leukemias and lymphomas. Its most serious side effect is …

Clinical application of doxorubicin (DOX), an anthracycline antibiotic with potent anti-tumor
effects, is limited because of its cardiotoxicity. However, its pathogenesis is still not entirely …

Clinical application of doxorubicin (DOX) is limited because of its cardiotoxicity. Thus,
exploration of effective lead compounds against DOX-induced cardiotoxicity is necessary …

Doxorubicin (DOX) is one of the most effective chemotherapeutic drugs; however, its
incidence of cardiotoxicity compromises its therapeutic index. Chrysin, a natural flavone …

Doxorubicin (DXR) is a highly effective drug for chemotherapy. However, cardiotoxicity
reduces its clinical utility in humans. The present study aimed to assess the ameliorative …

Background Doxorubicin (DOX) is commonly used in the treatment of many types of cancers
but its cardiotoxicity is limiting its clinical use. Beyond its anticoagulant action, enoxaparin …

The Vaccinium macrocarpon fruit extract was used to green synthesis of silver nanoparticles
(Ag NPs) supported on the surface of clinoptilolite through the reduction of Ag+ ions to Ag …

Aims Doxorubicin (DOX) is an anthracycline drug with a wide spectrum of clinical
antineoplastic activity, but increased apoptosis has been implicated in its cardiotoxicity …

Doxorubicin (DOXO), a potent and widely used chemotherapeutic agent, causes irreversible
heart failure by increasing oxidative stress, which limits its clinical utility. Nuclear factor …